Acute Leukemias (complete) Flashcards Preview

B&L Unit 2 > Acute Leukemias (complete) > Flashcards

Flashcards in Acute Leukemias (complete) Deck (24)
Loading flashcards...
1
Q

Describe leukemic stem cells

A
  • Potential for crazy amounts of self renewal
  • Also differentiate into leukemic blasts cells
  • THIS IS WHERE IT ALL BEGINS!
2
Q

What are the risk factors for acute leukemia? — Remember, however, that majority of acute leukemias occur in absence of risk factors

A

1) Previous chemo (remember DNA damage from alkylating agents or topoisomerase II inhibitors)
2) Tobacco smoke
3) Ionizing radiation
4) Benzene exposure
5) Genetic syndromes (e.g. Down syndrome, Bloom syndrome, Fanconi anemia, ataxia-telangiectasia)

3
Q

What are the common signs/symptoms exhibited by pts w/ acute leukemia at initial presentation?

A

Symptoms of anemia

1) Fatigue
2) Malaise
3) Dyspnea
4) Pallor

Symptoms of thrombocytopenia

1) Easy bruising
2) petechiae
3) Hemorrhage

Symptoms of neutropenia

1) Fever
2) Infections

4
Q

Why are the signs and symptoms exhibited by pts w/ acute leukemia at initial presentation?

A

Decreased #s of normal peripheral blood cells — b/c of marrow infiltration by leukemic cells

Low platelets
Low RBCs
Low neutrophils

5
Q

What are a few basic markers that would help to assign blasts to a precursor-B, precursor-T, or myeloid lineage?

A

Pre-B: CD19, CD22

Pre-T: CD3, CD7

Mye: CD34 (myeloblasts)

Lymph: TdT (lymphoblasts)

6
Q

Constrast B-ALL and T-ALL in regards to pt age and sex, manner of manifestation, and prognosis

A

For T-ALL compared to B-ALL…

Age: adolescents, YA

Sex: favors males

M: presents w/ a component of T-LBL, or mediastinal mass (B-ALL no lymphoma, only leukemia)
- Have markedly elevated WBC count

7
Q

What are 3 commonly observed cytogenetic abnormalities in B-ALL?

A

1) t(9;22)(q34;q11.2) — BCR-ABL1
2) t(11q23) — MLL
3) t(12;21)(p13;q22) — ETV6-RUNX1

8
Q

What is the usual pt age group and prognosis associated with BCR-ABL1?

A

Philadelphia chromosome (Ph+ ALL)

A: adults, children

P: worst prognosis of any subtype of ALL

9
Q

What is the usual pt age group and prognosis associated with MLL (ALL)?

A

A: neonates, young infants

P: poor

10
Q

What is the usual pt age group and prognosis associated with ETV6-RUNX1?

A

A: children

P: very favorable!

25% of cases in childhood B-ALL

11
Q

What are the 5 factors affecting prognosis in ALL? Worse prognosis in parentheses.

A

1) Age (less than 1yo, more than 10yo, adults)
2) WBC count (elevated @ diagnosis)
3) Slow response to therapy or small amounts of disease after therapy
4) # of chromosomes (<46 chromosomes)
5) B vs. T lineage (T has it bad)

12
Q

What are 2 types of findings that would allow for diagnosis of AML?

A

Increased myeloblasts accounting to >20% of nucleated cells in…

1) BM or
2) peripheral blood

13
Q

What is an Auer rod? What is its clinical significance?

A
  • Fused azurophilic granules forming small stick-like structures in cytoplasm
  • Only seen in abnormal myeloblasts
  • Can be used in diagnosis of AML!

W/o Auer rods, you can’t differentiate btwn myeloblasts and lymphoblasts in a smear

14
Q

What are the 5 recurrent cytogenetic abnormalities for AML?

A

1) t(8;21) — RUNX1-RUNX1T1
2) inv(16) or t(16;16) — CBFC-MYH11
3) t(15;17) — PML-RARA
4) t(1;22) — RBM15-MKL1
5) 11q23 —MLL

15
Q

What is the usual pt age group and prognosis associated with RUNX1-RUNX1T1 — t(8;21)?

A

A: younger pts (20s, 30s, 40s)

P: Good prognosis

16
Q

What is the usual pt age group and prognosis associated with CBFC-MYH11 — inv(16) or t(16;16)?

A

A: younger pts (20s, 30s, 40s)

P: Good prognosis

Associated w/ presence of abnormal eosinophilic percursors w/ abnormal basophilic granules and eos granules (BASOS EOS!!)

17
Q

What is the usual pt age group and prognosis associated with RBM15-MKL1 — t(1;22)?

A

A: infants w/ Down syndrome

P: Good prognosis

Shows megakaryoblastic differentiation

18
Q

What is the usual pt age group and prognosis associated with MLL (AML) — 11q23?

A

A: kids and adults

P: Poor prognosis

19
Q

Explain 2 reasons why it is important to recognize at initial diagnosis that a case of AML is the AML w/ t(15;17) subtype of AML (aka: acute promyelocytic leukemia, APL)

A

1) Encodes alpha-subunit of retinoic acid — signaling required for a receptor to begin differentiation past the promyelocyte stage
- A mutation in this is a problem!
- Can be mitigated w/ retinoic acid therapy

2) Associated w/ DIC (crazy clotting and hemorrhage)

20
Q

Contrast the 2 main categories of therapy-related AML. Talk about latency, cytogenetic abnormalities, and processes to AML through an MDS stage

A

1) Alkylating agents/radiation
2) Topoisomerase Inhibitors

AA/R vs TI

L: 2-8 y vs. 1-2 y

C: complex karyotype w/ whole/partial deletions in 5 or 7 vs. rearrangement of 11q23 (MLL)

MDS?: Usually yes vs. usually no

21
Q

Compare the prognosis of the 2 main categories of therapy-related AML

A

Both BADDDDDD

22
Q

What are the 3 molecular markers currently used to predict prognosis in pts w/ AML w/ normal karyotype?

A

1) FLT3 ITD
2) NPM1
3) CEBPA

23
Q

Of the 3 molecular markers currently used to predict prognosis in pts w/ AML w/ normal karyotype, which of these trumps the other 2 as a driving prognostic factor?

A

FLT3 ITD!

You only check for NPM-1 or CERPA if you are negative for FLT3

24
Q

What are the surface markers used to diagnose AML?

A

1) CD34 (lymphoblasts)
2) CD117 - C-Kit (myeloid marker)
3) Myeloperoxidase (myeloid marker)